Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by Lumberfeverlongon Sep 07, 2016 8:34am
160 Views
Post# 25213030

Short Squeeze Coming

Short Squeeze ComingJust like those are who bet against GBP are being squeezed so too will those holding a short position in CXR. Over 30% of CXR's float is currently short. The company is now trading below 1x2016 EBITDA. These valuation levels would suggest insolvency is right around the corner. Do your own research and you will also conclude that this is just completely impossible given company's balance sheet. With a deferral of half of the Cinven payment, the company will end the year with over $160M and still have a $200M undrawn revolver. Assuming no growth in 2017, hey should add more than $200M to that.  After payment of the other half of the CInven payment, they should be left with approximately $250M excess cash at the end of 2017. 

Worth underlining is the recent unexpected rise in the GBP which is now trading at 1.34 USD to GBP.  Company's guidance assumed an exchange rate of 1.31.  Economic data coming out of the UK recently suggests the British pound will continue its ascent. This bodes well for CXr as over 60% of its revenue derives from Amco now. The short and distort gang will say that they missed the boat on this because of their swap arrangement, but that arrangement only swapped debt from USD to GBP.  Revenue is not hedged meaning as the GBP appreciates so too will USD denominated revenue. 

Do do not sell your shares at these levels. Put in sell orders at $50 or above so the shorts can't use your shares for shorting. The squeeze is coming. Be patient. Look away!!!


<< Previous
Bullboard Posts
Next >>